WallStSmart

Merck & Company Inc (MRK)vsSenseonics Holdings, Inc. Common Stock (SENS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Merck & Company Inc generates 186439% more annual revenue ($65.77B vs $35.26M). MRK leads profitability with a 13.6% profit margin vs -196.0%. MRK earns a higher WallStSmart Score of 50/100 (D+).

MRK

Hold

50

out of 100

Grade: D+

Growth: 3.3Profit: 8.0Value: 2.7Quality: 5.0
Piotroski: 3/9Altman Z: 2.30

SENS

Avoid

24

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 5.5
Piotroski: 5/9Altman Z: -11.23
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MRKSignificantly Overvalued (-49.3%)

Margin of Safety

-49.3%

Fair Value

$80.88

Current Price

$120.79

$39.91 premium

UndervaluedFair: $80.88Overvalued

Intrinsic value data unavailable for SENS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MRK3 strengths · Avg: 9.3/10
Market CapQuality
$285.64B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
38.6%10/10

Strong operational efficiency at 38.6%

Free Cash FlowQuality
$2.93B8/10

Generating 2.9B in free cash flow

SENS1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
71.8%10/10

Revenue surging 71.8% year-over-year

Areas to Watch

MRK4 concerns · Avg: 3.5/10
P/E RatioValuation
32.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
4.9%4/10

4.9% revenue growth

Debt/EquityHealth
1.073/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

SENS4 concerns · Avg: 3.5/10
Price/BookValuation
8.1x4/10

Trading at 8.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$357.07M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.263/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : MRK

The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.

Bull Case : SENS

The strongest argument for SENS centers on Revenue Growth. Revenue growth of 71.8% demonstrates continued momentum.

Bear Case : MRK

The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.

Bear Case : SENS

The primary concerns for SENS are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

MRK profiles as a value stock while SENS is a hypergrowth play — different risk/reward profiles.

SENS carries more volatility with a beta of 1.06 — expect wider price swings.

SENS is growing revenue faster at 71.8% — sustainability is the question.

MRK generates stronger free cash flow (2.9B), providing more financial flexibility.

Bottom Line

MRK scores higher overall (50/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Merck & Company Inc

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.

Visit Website →

Senseonics Holdings, Inc. Common Stock

HEALTHCARE · MEDICAL DEVICES · USA

Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland.

Visit Website →

Want to dig deeper into these stocks?